GlassScriptPhysician profile
Gregory Krenek
NPI 1669563458
$4,601.17
in general payments reported to CMS, 2019-2025
19 companies · $1,483 in 2025
The $1,483 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $347 · 2020: $178 · 2021: $459 · 2022: $586 · 2023: $564 · 2024: $984 · 2025: $1,483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,676 · Education: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,676.17 |
| Education | $355.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,124.75 | 2019-2025 | Tremfya, Simponi Aria, Stelara |
| Abbvie INC. | $859.77 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $806.85 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $349.80 | 2020-2025 | Ilumya, Absorica Ld, Winlevi |
| Ucb, INC. | $246.28 | 2021-2025 | Cimzia, Bimzelx |
| Lilly USA, LLC | $227.65 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Leo Pharma INC. | $195.07 | 2019-2025 | Adbry |
| Amgen INC. | $194.17 | 2024-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $126.16 | 2019-2025 | Nemluvio |
| E.R. Squibb & Sons, L.L.C. | $97.14 | 2024-2025 | Sotyktu |
| Genzyme Corporation | $84.62 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $78.39 | 2021 | |
| Biocon Biologics INC | $46.75 | 2024-2025 | Yesintek, Hulio |
| Vyne Pharmaceuticals INC. | $43.08 | 2020 | |
| Dermavant Sciences, INC. | $38.46 | 2023-2024 | Vtama |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $38.31 | 2025 | Siliq, Cabtreo, Jublia |
| Epi Health, LLC | $20.54 | 2019 | |
| Genentech USA, INC. | $20.45 | 2019 | |
| Journey Medical Corporation | $2.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Krenek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.